Logo image of MNST

MONSTER BEVERAGE CORP (MNST) Stock Fundamental Analysis

NASDAQ:MNST - Nasdaq - US61174X1090 - Common Stock - Currency: USD

60.35  +1.33 (+2.25%)

After market: 60.35 0 (0%)

Fundamental Rating

6

Overall MNST gets a fundamental rating of 6 out of 10. We evaluated MNST against 32 industry peers in the Beverages industry. MNST gets an excellent profitability rating and is at the same time showing great financial health properties. MNST is valied quite expensively at the moment, while it does show a decent growth rate. With these ratings, MNST could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

MNST had positive earnings in the past year.
In the past year MNST had a positive cash flow from operations.
Each year in the past 5 years MNST has been profitable.
In the past 5 years MNST always reported a positive cash flow from operatings.
MNST Yearly Net Income VS EBIT VS OCF VS FCFMNST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

The Return On Assets of MNST (18.35%) is better than 96.88% of its industry peers.
Looking at the Return On Equity, with a value of 23.16%, MNST is in the better half of the industry, outperforming 78.13% of the companies in the same industry.
The Return On Invested Capital of MNST (23.04%) is better than 96.88% of its industry peers.
MNST had an Average Return On Invested Capital over the past 3 years of 19.65%. This is significantly above the industry average of 11.51%.
The 3 year average ROIC (19.65%) for MNST is below the current ROIC(23.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 18.35%
ROE 23.16%
ROIC 23.04%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
MNST Yearly ROA, ROE, ROICMNST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 20.27%, MNST belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
MNST's Profit Margin has declined in the last couple of years.
The Operating Margin of MNST (28.00%) is better than 84.38% of its industry peers.
MNST's Operating Margin has declined in the last couple of years.
The Gross Margin of MNST (54.64%) is better than 65.63% of its industry peers.
MNST's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 28%
PM (TTM) 20.27%
GM 54.64%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
MNST Yearly Profit, Operating, Gross MarginsMNST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MNST is creating value.
The number of shares outstanding for MNST has been reduced compared to 1 year ago.
MNST has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MNST has a worse debt to assets ratio.
MNST Yearly Shares OutstandingMNST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
MNST Yearly Total Debt VS Total AssetsMNST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 23.73 indicates that MNST is not in any danger for bankruptcy at the moment.
MNST has a Altman-Z score of 23.73. This is amongst the best in the industry. MNST outperforms 100.00% of its industry peers.
The Debt to FCF ratio of MNST is 0.12, which is an excellent value as it means it would take MNST, only 0.12 years of fcf income to pay off all of its debts.
MNST's Debt to FCF ratio of 0.12 is amongst the best of the industry. MNST outperforms 87.50% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that MNST is not too dependend on debt financing.
MNST has a better Debt to Equity ratio (0.03) than 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.12
Altman-Z 23.73
ROIC/WACC2.6
WACC8.87%
MNST Yearly LT Debt VS Equity VS FCFMNST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 3.37 indicates that MNST has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.37, MNST belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
MNST has a Quick Ratio of 2.78. This indicates that MNST is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.78, MNST belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 2.78
MNST Yearly Current Assets VS Current LiabilitesMNST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.75% over the past year.
Measured over the past years, MNST shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.72% on average per year.
Looking at the last year, MNST shows a small growth in Revenue. The Revenue has grown by 1.47% in the last year.
Measured over the past years, MNST shows a quite strong growth in Revenue. The Revenue has been growing by 12.27% on average per year.
EPS 1Y (TTM)3.75%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%11.9%
Revenue 1Y (TTM)1.47%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%-2.35%

3.2 Future

MNST is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.04% yearly.
The Revenue is expected to grow by 8.05% on average over the next years. This is quite good.
EPS Next Y17.3%
EPS Next 2Y14.48%
EPS Next 3Y12.93%
EPS Next 5Y15.04%
Revenue Next Year6.23%
Revenue Next 2Y7.13%
Revenue Next 3Y7.13%
Revenue Next 5Y8.05%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MNST Yearly Revenue VS EstimatesMNST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
MNST Yearly EPS VS EstimatesMNST Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 36.36, MNST can be considered very expensive at the moment.
MNST's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.24. MNST is valued slightly more expensive when compared to this.
MNST is valuated quite expensively with a Price/Forward Earnings ratio of 28.60.
MNST's Price/Forward Earnings is on the same level as the industry average.
MNST is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 36.36
Fwd PE 28.6
MNST Price Earnings VS Forward Price EarningsMNST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MNST is valued a bit more expensive than the industry average as 65.63% of the companies are valued more cheaply.
MNST's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 32.75
EV/EBITDA 25.74
MNST Per share dataMNST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MNST does not grow enough to justify the current Price/Earnings ratio.
MNST has an outstanding profitability rating, which may justify a higher PE ratio.
MNST's earnings are expected to grow with 12.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.1
PEG (5Y)N/A
EPS Next 2Y14.48%
EPS Next 3Y12.93%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNST!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONSTER BEVERAGE CORP

NASDAQ:MNST (8/4/2025, 5:43:35 PM)

After market: 60.35 0 (0%)

60.35

+1.33 (+2.25%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners68.16%
Inst Owner Change0.11%
Ins Owners0.49%
Ins Owner Change6.58%
Market Cap58.86B
Analysts75
Price Target63.61 (5.4%)
Short Float %2.99%
Short Ratio3.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.6%
Min EPS beat(2)-6.99%
Max EPS beat(2)-0.21%
EPS beat(4)0
Avg EPS beat(4)-6.73%
Min EPS beat(4)-11.44%
Max EPS beat(4)-0.21%
EPS beat(8)1
Avg EPS beat(8)-4.52%
EPS beat(12)2
Avg EPS beat(12)-5.44%
EPS beat(16)3
Avg EPS beat(16)-4.89%
Revenue beat(2)0
Avg Revenue beat(2)-4.61%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)-0.98%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)-0.98%
Revenue beat(8)0
Avg Revenue beat(8)-3.85%
Revenue beat(12)1
Avg Revenue beat(12)-3.56%
Revenue beat(16)4
Avg Revenue beat(16)-1.96%
PT rev (1m)0.13%
PT rev (3m)7.08%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)3.99%
EPS NY rev (1m)-0.34%
EPS NY rev (3m)1.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.02%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.73%
Valuation
Industry RankSector Rank
PE 36.36
Fwd PE 28.6
P/S 7.9
P/FCF 32.75
P/OCF 29.08
P/B 9.03
P/tB 15.6
EV/EBITDA 25.74
EPS(TTM)1.66
EY2.75%
EPS(NY)2.11
Fwd EY3.5%
FCF(TTM)1.84
FCFY3.05%
OCF(TTM)2.08
OCFY3.44%
SpS7.64
BVpS6.68
TBVpS3.87
PEG (NY)2.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.35%
ROE 23.16%
ROCE 29.78%
ROIC 23.04%
ROICexc 31.64%
ROICexgc 68.61%
OM 28%
PM (TTM) 20.27%
GM 54.64%
FCFM 24.13%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
ROICexc(3y)29.02%
ROICexc(5y)32.32%
ROICexgc(3y)64.44%
ROICexgc(5y)84.58%
ROCE(3y)25.4%
ROCE(5y)26.54%
ROICexcg growth 3Y-12.83%
ROICexcg growth 5Y-13.62%
ROICexc growth 3Y-5.49%
ROICexc growth 5Y-2.02%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
F-Score7
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.12
Debt/EBITDA 0.09
Cap/Depr 267.77%
Cap/Sales 3.05%
Interest Coverage 71.04
Cash Conversion 93.27%
Profit Quality 119%
Current Ratio 3.37
Quick Ratio 2.78
Altman-Z 23.73
F-Score7
WACC8.87%
ROIC/WACC2.6
Cap/Depr(3y)319.34%
Cap/Depr(5y)225.06%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.29%
Profit Quality(3y)86.9%
Profit Quality(5y)86.95%
High Growth Momentum
Growth
EPS 1Y (TTM)3.75%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%11.9%
EPS Next Y17.3%
EPS Next 2Y14.48%
EPS Next 3Y12.93%
EPS Next 5Y15.04%
Revenue 1Y (TTM)1.47%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%-2.35%
Revenue Next Year6.23%
Revenue Next 2Y7.13%
Revenue Next 3Y7.13%
Revenue Next 5Y8.05%
EBIT growth 1Y3.72%
EBIT growth 3Y4.5%
EBIT growth 5Y7.79%
EBIT Next Year15.46%
EBIT Next 3Y11.01%
EBIT Next 5Y11.74%
FCF growth 1Y62.57%
FCF growth 3Y14.4%
FCF growth 5Y10.46%
OCF growth 1Y54.2%
OCF growth 3Y18.61%
OCF growth 5Y11.61%